?(N)-Heterocyclic Thiosemicarbazones: Iron Chelators that are Promising for Revival of Gallium in Cancer Chemotherapy

E-ISSN： 1875-5992|16|8|973-991

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.16, Iss.8, 2016-07, pp. : 973-991

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell Permeable Iron Chelators as Potential Cancer Chemotherapeutic Agents

By Pahl Paula Horwitz Lawrence

Cancer Investigation, Vol. 23, Iss. 8, 2005-11 ,pp. : 683-691

Informa Healthcare

Access to resources Recommend Favorite

Antiproliferative and Apoptotic Effects of Iron Chelators on Human Cervical Carcinoma Cells

By Simonart T. Boelaert J.R. Mosselmans R. Andrei G. Noel J.-C. De Clercq E. Snoeck R.

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 95-102

Elsevier

Access to resources Recommend Favorite

Telomerase and Cancer: A Promising Target

By Maria Laura Falchetti

American Journal of Cancer, Vol. 3, Iss. 1, 2004-01 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

A promising cancer vaccine

By De Leon Gabriel Mitchell Duane Sampson John

Future Oncology, Vol. 7, Iss. 3, 2011-03 ,pp. : 331-334

Future Medicine

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy and Targeted Therapies: a Promising Strategy

By Metzger-Filho Otto de Azambuja Evandro

Journal of the National Cancer Institute Monographs, Vol. 2011, Iss. 43, 2011-10 ,pp. : 116-119

Oxford University Press

Access to resources Recommend Favorite